Toagosei Co., Ltd.

Toagosei Co., Ltd.

TOAGF
Toagosei Co., Ltd.US flagOther OTC
10.73
USD
- -
- -
1.14BMarket Cap
Toagosei Co., Ltd.
TOAGF
(Other OTC)

Recent

price

10.73

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
1,218.89
1,200.39
1,124.24
1,146.42
1,130.55
1,062.16
1,028.37
1,099.28
1,140.04
1,101.26
1,022.85
1,227.46
1,304.03
1,344.93
1,475.43
1,487.84
1,424.47
Revenue per Share
104.1
101.99
73.57
72.88
63.88
50.86
104.83
98.08
96.85
78.91
62.43
108.14
101.31
102.78
104.56
117.02
119.44
Basic EPS, GAAP
120.11
58.65
79.39
84.27
54.99
141.71
118.81
66.68
62.09
25.13
47.49
76.19
-75.46
84.2
-21.29
-83.64
- -
Free Cash Flow per Basic Share
13.01
20.44
19.97
19.99
22.04
23.99
24.95
25.99
26.99
29.04
30.15
32.18
37.29
38.42
63.89
63.46
- -
Dividend per Share
776.9
844.5
870.14
923.3
965.65
997.81
1,077.77
1,149.92
1,219.82
1,269.79
1,294.2
1,370.89
1,451.72
1,522.79
1,573.73
1,625.06
1,595.05
Book Value per Share
980.74
993.97
1,026.63
1,117.98
1,190.2
1,234.43
1,310.32
1,420.4
1,448.39
1,503.12
1,509.5
1,609.31
1,696.38
1,780.1
1,866.37
1,936.16
1,870.37
Tangible Book Value per Share
126
127
132
132
132
132
132
132
132
132
130
127
123
118
114
109
115
Basic Weighted Avg Shares
153,779
153,007
148,203
151,081
148,912
139,848
135,382
144,708
150,066
144,955
133,392
156,313
160,825
159,371
167,594
162,312
163,995
Sales/Revenue/Turnover
13.83
11.33
9.84
9.6
8.07
8.83
11.93
12.06
10.93
9.51
9.25
11.31
8.94
7.84
8.49
8.74
9.19
Operating Margin (%)
8,847
9,118
8,431
7,654
8,677
8,866
7,974
7,944
8,374
9,257
9,848
10,623
10,457
10,656
11,302
11,652
- -
Depreciation Expense
13,133
13,000
9,699
9,605
8,414
6,696
13,801
12,911
12,748
10,387
8,142
13,771
12,494
12,179
11,877
12,766
13,751
Net Income, GAAP
22.37
28.21
30.76
32.97
33.87
40.23
31.28
29.13
25.91
30.31
31.74
25.64
26.34
28.44
27.72
25.97
27.73
Effective Tax Rate (%)
8.54
8.5
6.54
6.36
5.65
4.79
10.19
8.92
8.49
7.17
6.1
8.81
7.77
7.64
7.09
7.87
8.39
Profit Margin (%)
48,470
58,578
59,495
67,447
76,918
85,719
99,591
100,241
107,019
106,048
98,039
108,431
101,193
93,380
73,997
63,180
82,762
Working Capital
6,200
9,439
6,144
5,986
10,457
10,048
9,886
5,735
9,283
9,282
4,700
8,870
9,727
9,672
5,896
14,744
4,930
LT Debt
125,027
127,777
136,238
148,147
157,348
163,018
173,000
187,485
191,294
198,578
197,640
206,610
210,806
212,517
213,667
215,943
216,990
Total Equity
12.01
8.7
6.84
6.14
4.74
4.22
6.03
6.32
5.96
4.59
3.98
6.07
4.74
3.95
4.51
4.48
4.8
Return on Invested Capital (%)
10.32
9.98
7.39
6.96
5.76
4.33
8.72
7.71
7.29
5.64
4.32
7.25
6.36
6.27
6.17
6.56
7.06
Return on Capital (%)
14.23
12.64
8.72
8.13
6.76
5.18
10.1
8.81
8.17
6.34
4.85
8.02
7.07
6.78
6.61
7.17
7.51
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Dec'23
Mar'24
Jun'24
ST Debt
2,673
2,515
6,220
LT Borrowings
8,595
8,694
4,930
LT Finance Leases
1,077
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
116
114
113
Market Capitalization
148,937
165,115
175,508

Working Capital

FRC

in mil. unless spec.
Dec'23
Mar'24
Jun'24
Total Current Assets
134,860
125,118
129,895
Cash, Cash Equivalents & STI
56,108
48,392
51,038
Accounts Receivable, Net
42,237
48,012
50,135
Inventories
24,792
25,050
25,591
Total Current Liabilities
41,480
39,427
47,133
Payables & Accruals
- -
- -
- -
ST Debt
2,673
2,515
6,220
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
2.88%
1.8%
1.07%
Free Cash Flow
-23.26%
-38.66%
277.38%
Net Income, GAAP
12.06%
12.47%
7.49%
Sales/Revenue/Turnover
1.72%
4.24%
-3.15%
Total Cash Common Dividend
9.27%
14.05%
-4.6%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
38,198
38,749
39,202
43,222
159,371
2024
39,014
42,557
- -
- -
167,594
2025
- -
- -
- -
- -
162,312

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
18.18
- -
- -
- -
102.78
2024
23.6
- -
- -
- -
104.56
2025
- -
- -
- -
- -
117.02

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
38.42
2024
- -
- -
- -
- -
63.89
2025
- -
- -
- -
- -
63.46
Business
Toagosei Co., Ltd. and its affiliated entities engage in the global development, manufacturing, and distribution of an extensive array of chemical goods. The enterprise conducts operations across several distinct divisions: Commodity Chemicals, Polymer & Oligomer, Adhesive Material, Performance Chemicals, and Plastics. Within its Commodity Chemicals segment, the company offers foundational products such as liquid caustic soda, liquid chlorine, synthetic hydrochloric acid, and sodium hypochlorite, alongside various potassium-based compounds including caustic potash and potassium pyrophosphate. Additionally, it provides sulfuric acid and a selection of industrial gases, including oxygen, nitrogen, and argon, vital for numerous industrial applications. The Polymer & Oligomer division is responsible for acrylic monomers, such as acrylic acid and acrylic esters, as well as a broad spectrum of acrylic polymers utilized as dispersants, thickeners, scale inhibitors, and binders. This segment further encompasses polymer flocculants and advanced UV-curable resins. The Adhesive Material business is recognized for its leading instant adhesives, notably the Aron Alpha brand, known internationally as Krazy Glue, and a variety of specialized functional adhesives. Meanwhile, Performance Chemicals focuses on high-purity inorganic chemicals, including electronic materials and amenity care products, alongside other innovative specialized solutions like recent dental hemostatic agents. The Plastics segment delivers piping equipment, essential materials for construction and civil engineering projects, nursing care items, and elastomer compounds. Founded in 1933, the company is headquartered in Tokyo, Japan, and maintains a worldwide operational footprint. Toagosei focuses on leveraging chemical possibilities to deliver highly functional materials, expanding its global presence and committing to sustainable practices and innovation. Recent strategic moves include establishing a new subsidiary in India and expanding manufacturing for lithium-ion battery binders, alongside ongoing research initiatives in advanced materials and pharmaceuticals.